F11R, F11 receptor, 50848

N. diseases: 127; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.020 Biomarker disease BEFREE These results demonstrate that therapeutic targeting of JAM-A has the potential to prevent MM progression, and lead us to propose JAM-A as a biomarker in MM, and sJAM-A as a serum-based marker for clinical stratification. 29064484 2018
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.020 AlteredExpression disease BEFREE Notably, analysis of paired primary MM specimens revealed that JAM-A expression was significantly increased at relapse compared to diagnosis. 26513296 2015